| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | EP1295607B1 Antitumor effect potentiators |
| 04/28/2010 | CN1961888B Lyophilized powder injection of baikal skullcap root extract and preparation method thereof |
| 04/28/2010 | CN1940062B Liver-cancer stem cell, its separation and use |
| 04/28/2010 | CN1935195B Method for extracting female sex hormone from polygonum cuspidatum |
| 04/28/2010 | CN1923247B Medicine for eliminating cancer pain drastically and curing late cancers and its preparation method |
| 04/28/2010 | CN1904041B Human recombination phospholipase D2, its preparation method and application in preparation medicine |
| 04/28/2010 | CN1872851B Compound of alpha - methylene - gamma - butyrolactone, preparation method, and method |
| 04/28/2010 | CN1814292B Anti-cancer prodrug, preparing method and use |
| 04/28/2010 | CN1809586B Biologically active peptide comprising tyrosyl-seryl-valine (YSV) |
| 04/28/2010 | CN1798762B Tuberculosis vaccine with improved efficacy |
| 04/28/2010 | CN1795183B Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 04/28/2010 | CN1771235B Isoxazole compounds |
| 04/28/2010 | CN1767848B Survivin-derived peptides and use thereof |
| 04/28/2010 | CN1761686B Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/28/2010 | CN1761485B Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 04/28/2010 | CN1705683B Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 04/28/2010 | CN1700917B Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 04/28/2010 | CN1689638B Cosmetic powder |
| 04/28/2010 | CN1676521B Kuh-seng ketone and its derivative and the like and use in preparing anti-tumor medicine |
| 04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/28/2010 | CN1652698B Method and dietary composition for improving lipid digestibility |
| 04/28/2010 | CN1652697B Method and dietary composition for improving fat digestibility |
| 04/28/2010 | CN1652696B Method of improving absorption of vitamin E by a pet animal |
| 04/28/2010 | CN1596266B Specific binding agents of human angiopoietin-2 |
| 04/28/2010 | CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine, |
| 04/28/2010 | CN1556705B 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives |
| 04/28/2010 | CN1553906B VARIOLIN derivatives and their use as antitumor agents |
| 04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
| 04/28/2010 | CN1434043B Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 04/28/2010 | CN101698852A Protein or polypeptide with function of CD137L, and gene and application thereof |
| 04/28/2010 | CN101698816A Coix seed wine and coix seed ginseng root wine |
| 04/28/2010 | CN101698651A Salicylanilide derivatives, preparation method thereof and application thereof |
| 04/28/2010 | CN101698089A Traditional Chinese medicine volatile oil clathrate compound and preparation method thereof |
| 04/28/2010 | CN101698083A Medicament for preventing and treating lung cancer and preparation method thereof |
| 04/28/2010 | CN101698071A Anticancer capsule |
| 04/28/2010 | CN101698038A Paster for treating cancer pain and preparation method thereof |
| 04/28/2010 | CN101698035A Method for preparing anti-tumor active ingredients of Chinese fan palm |
| 04/28/2010 | CN101698031A Method for separating short-tube lycoris total alkaloids by ion exchange resin |
| 04/28/2010 | CN101698021A Method for separating acutangular anisodus root total alkaloids by ion exchange resin |
| 04/28/2010 | CN101698003A Method for separating rhizoma corydalis total alkaloids by ion exchange resin |
| 04/28/2010 | CN101697991A Method for separating leontice robustum total alkaloids by ion exchange resin |
| 04/28/2010 | CN101697981A Fast, non-heat change and high-efficiency method for breaking ganoderma lucidum spore |
| 04/28/2010 | CN101697979A Officinal fungus mycelium extract and preparation method thereof |
| 04/28/2010 | CN101697972A Application of neoaspergillic acid in preparing antitumor drugs |
| 04/28/2010 | CN101697971A Rehabilitation therapy method for lung cancer |
| 04/28/2010 | CN101697964A Combretaftation A-4P frozen preparation and preparation method thereof |
| 04/28/2010 | CN101697963A Method for preparing PLGA slow-release microsphere carrying docetaxel and application thereof in chemotherapy of mesenchyma stroma of tumors under ultrasonic mediation |
| 04/28/2010 | CN101697962A Process for preparing matrine-loaded magnetic chitosan microspheres |
| 04/27/2010 | US7705196 sFRP expression enhancing agent |
| 04/27/2010 | US7705195 Screening method |
| 04/27/2010 | US7705182 Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 04/27/2010 | US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases |
| 04/27/2010 | US7705027 Isoxazole compounds as inhibitors of heat shock proteins |
| 04/27/2010 | US7705016 administering small molecule capable of inhibiting CPT1(carnitine palmitoyl transferase1) is 2-tetradecylglydate (TDGA) or (R)-N-(tetradecylcarbamoyl)-aminocarnitine |
| 04/27/2010 | US7705015 Substituted pyrroline kinase inhibitors |
| 04/27/2010 | US7705006 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/27/2010 | US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase |
| 04/27/2010 | US7704995 Protein kinase modulators and methods of use |
| 04/27/2010 | US7704971 Uracil reductase inactivators |
| 04/27/2010 | US7704969 Transfection complexes |
| 04/27/2010 | US7704965 Methods and materials for treating human papillomavirus infections |
| 04/27/2010 | US7704964 Methods and compounds for the targeting of protein to exosomes |
| 04/27/2010 | US7704963 Administering as antitumor or anticarcinogenic agent; interference RNA |
| 04/27/2010 | US7704962 Small oligonucleotides with anti-tumor activity |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704943 Angiogenesis inhibitors; using transglutaminase; antitumor agents; anticancer agents |
| 04/27/2010 | US7704924 Library of compounds comprising pyrrolobenzodiazepine moieties |
| 04/27/2010 | US7704709 Recombinant cytokine protein for use in treatment of leukemia |
| 04/27/2010 | US7704525 Lipid microparticles by cryogenic micronization |
| 04/27/2010 | US7704516 Administration be done percutaneously (topically), to avoid the first-pass effect and related liver metabolism of the 4-hydroxy tamoxifen; side effect reduction |
| 04/27/2010 | US7704506 Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same |
| 04/27/2010 | CA2665543C Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/27/2010 | CA2476494C Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 04/27/2010 | CA2468479C Podophyllotoxins as antiproliferative agents |
| 04/27/2010 | CA2462939C Novel derivatives of isoquinoline, process for their preparation and pharmaceutical compositions containing them |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor |
| 04/27/2010 | CA2328431C Plasmin inhibitors from the australian brown snake pseudonaja textilis textilis |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2321149C Antitumor agents |
| 04/27/2010 | CA2293692C Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/22/2010 | WO2010045624A1 Inhibitors of mitosis for increasing apoptosis in therapy |
| 04/22/2010 | WO2010045601A2 Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents |
| 04/22/2010 | WO2010045586A2 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 04/22/2010 | WO2010045573A2 Tumor vaccine |
| 04/22/2010 | WO2010045558A1 Method of determining a phosphorus binder dosage for a dialysis patient |
| 04/22/2010 | WO2010045542A2 Fused ring heteroaryl kinase inhibitors |
| 04/22/2010 | WO2010045469A2 Muc18 targeting peptides |
| 04/22/2010 | WO2010045395A2 Curcumin analog compositions and related methods |
| 04/22/2010 | WO2010045379A2 Pyridine non-classical cannabinoid compounds and related methods of use |
| 04/22/2010 | WO2010045377A2 Pyrimidine non-classical cannabinoid compounds and related methods of use |
| 04/22/2010 | WO2010045369A2 Fas/fasl or other death receptor targeted methods and compositions for killing tumor cells |
| 04/22/2010 | WO2010045344A1 Combination therapy comprising a c-met antagonist and a vegf antagonist |
| 04/22/2010 | WO2010045281A2 Stable aqueous formulations of water insoluble or poorly soluble drugs |
| 04/22/2010 | WO2010045199A2 Method of modulating ship activity |
| 04/22/2010 | WO2010045190A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010044753A1 Novel benzylidene-indolinone and their medical and diagnostic uses |